Calmark presents at Stockholm Corporate Finance 12th Life Science seminar

Calmark attends Stockholm Corporate Finance 12th Life Science Seminar that will be held at Berns on March 11 - 12, 2020. CEO Anna Söderlund presents the latest developments and the future prospects for the company at 10:45 on March 12. The presentation is held in Swedish at Berns and will also be broadcast live at the same time.

For the twelfth year in a row, Stockholm Corporate Finance organizes the Capital Markets Day and offers investors, analysts and media to meet companies in the Life Science & Healthcare industry.

The presentation will be streamed and can be viewed directly online by clicking on the link: https://financialhearings.com/event/12254


Every care has been taken in the translation of this document. In the event of discrepancies, the Swedish original will supersede the English translation.
 

For more information about Calmark Sweden AB, please contact:

Anna Söderlund, CEO
Telefon: +46 70 213 25 35
E-post: anna.soderlund@calmark.se 
www.calmark.se 

Calmark Sweden AB is a medical technology company developing a point-of-care (POC) analyzis method with easier and faster sampling of medical conditions in newborns. The unique test platform, which consists of a reader and single-use products, is expected to be ready for launch in 2020 when three important POC tests are introduced. The WHO estimates that 1.5 billion children will be born worldwide by 2030. In the Western world, the introduction of POC diagnostics is resulting in huge savings and shorter healthcare chains. In less developed healthcare systems, the product helps save lives. Calmark aims to become the global leader and ultimately to offer all relevant POC tests for the first period of life, regardless of where in the world a baby is born. Read more about Calmark www.calmark.se/eng/home.  

Subscribe

Documents & Links